03/03/2021
MSHO Featured Corporate Sponsor Assistance Program
Natera Signatera
The first personalized ctDNA test to identify molecular residual disease and optimize treatment decisions.
At Natera, we understand that some of our patients are unable to pay for our services due to financial hardship or other circumstances. That's why, through our Compassionate Care Program, patients who qualify will pay no more than $149 per test, and may owe nothing, depending on their financial situation.
MSHO will profile a different Corporate Sponsor Assistance Program in each Bulletin. To view more Patient Assistance Programs, click here.